Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,678 | -40,977 | -102,678 | -95,223 | -40,707 |
| Depreciation Amortization | 14,095 | 32,517 | 22,448 | 15,518 | 9,963 |
| Accounts receivable | -2,396 | 40 | 152 | 1,346 | 1,431 |
| Accounts payable and accrued liabilities | 6,305 | -3,103 | -2,708 | 6,991 | -2,811 |
| Other Working Capital | 1,921 | -2,668 | 10,613 | 7,820 | 1,309 |
| Other Operating Activity | 20,152 | -6,301 | 47,215 | 42,155 | 13,321 |
| Operating Cash Flow | $-39,601 | $-20,492 | $-24,958 | $-21,393 | $-17,494 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,186 | -7,432 | -168,590 | -123,654 | 34,046 |
| PPE Investments | -21 | -19 | -727 | -727 | -601 |
| Purchase Of Investment | N/A | N/A | -15,000 | -15,000 | -15,000 |
| Purchase Sale Intangibles | -7,347 | -3,961 | -18,974 | -15,108 | -11,389 |
| Other Investing Activity | -7,347 | -3,961 | -18,974 | -15,108 | -11,389 |
| Investing Cash Flow | $13,818 | $-11,412 | $-203,291 | $-154,489 | $7,056 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 235,797 | 235,797 | N/A |
| Common Stock Issued | 317 | 304 | 15,893 | 14,653 | 9,030 |
| Other Financing Activity | -1,751 | -1,414 | -19,827 | -19,112 | -8,647 |
| Financing Cash Flow | $-1,434 | $-1,110 | $231,863 | $231,338 | $383 |
| Exchange Rate Effect | 1 | -21 | -135 | -30 | -34 |
| Beginning Cash Position | 102,873 | 102,873 | 99,394 | 99,394 | 99,394 |
| End Cash Position | 75,657 | 69,838 | 102,873 | 154,820 | 89,305 |
| Net Cash Flow | $-27,216 | $-33,035 | $3,479 | $55,426 | $-10,089 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,601 | -20,492 | -24,958 | -21,393 | -17,494 |
| Capital Expenditure | -21 | -19 | -727 | -727 | -601 |
| Free Cash Flow | -39,622 | -20,511 | -25,685 | -22,120 | -18,095 |